From Manufacturing To Market: How This EU Pharma Co. Fast-Tracked Cannabis Production

Published by

European pharmaceutical cannabis product manufacturer SOMAÍ Pharmaceuticals Unipessoal LDA received authorization for its facility in Lisbon, Portugal, from the Portuguese Health Authority INFRAMED. Why It MattersThis authorization allows the company to produce, import, and export medicinal cannabis products to numerous global markets. It awards SOMAÍ a GMP Certificate Part I and Part II, enabling it to execute its plan to own distribution channels in Australia and Germany and to establish distribution partnerships in another eight countries while developing a comprehensive brand of medical ca…

Read More

See also  Conservatives are atwitter over Ocasio-Cortez's trip to Florida

Leave a Reply